1-7 of 7
Leslie Carter
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Meeting Abstracts

1578-P: Circulating Mitochondrial DNA Provides a Novel Biomarker for Hyperinsulinemia and Disease Severity in Type 2 Diabetes

Free
ROBERT L. THOMAS__III, JESSE D. GARCIA, AVNEE J. KUMAR, LESLIE CARTER, JORGE A. MASSO-SILVA, VALA HAMIDI, SCHAFER C. BOEDER, THEODORE P. CIARALDI, JEREMY H. PETTUS, MARK L. HEPOKOSKI
Journal: Diabetes
Diabetes 2025;74(Supplement_1):1578-P
https://doi.org/10.2337/db25-1578-P
Published: 20 June 2025
View articletitled, 1578-P: Circulating Mitochondrial DNA Provides a Novel Biomarker for Hyperinsulinemia and Disease Severity in Type 2 Diabetes
Meeting Abstracts

269-OR: Glucagon Antagonism Improves Insulin Sensitivity and Increases Lean Body Mass in Patients with Type 1 Diabetes—A Twelve-Week Double-Blind, Randomized, Placebo-Controlled Trial

Free
SCHAFER C. BOEDER, ROBERT L. THOMAS, VALA HAMIDI, ERIN R. GIOVANNETTI, ADRIENNE ARMSTRONG, LESLIE CARTER, THEODORE P. CIARALDI, JEREMY H. PETTUS
Journal: Diabetes
Diabetes 2025;74(Supplement_1):269-OR
https://doi.org/10.2337/db25-269-OR
Published: 20 June 2025
View articletitled, 269-OR: Glucagon Antagonism Improves Insulin Sensitivity and Increases Lean Body Mass in Patients with Type 1 Diabetes—A Twelve-Week Double-Blind, Randomized, Placebo-Controlled Trial
Meeting Abstracts

267-OR: ADA Presidents' Select Abstract: Combining an SGLT Inhibitor with a Glucagon Receptor Agonist (GRA) in Subjects with Type 1 Diabetes—A Randomized Clinical Trial

Free
SCHAFER C. BOEDER, MELISSA J. LE ROUX, ERIN R. GIOVANNETTI, ADRIENNE ARMSTRONG, LESLIE CARTER, ROBERT L. THOMAS, JUSTIN M. GREGORY, JEREMY PETTUS
Journal: Diabetes
Diabetes 2023;72(Supplement_1):267-OR
https://doi.org/10.2337/db23-267-OR
Published: 20 June 2023
View articletitled, 267-OR: ADA Presidents' Select Abstract: Combining an SGLT Inhibitor with a Glucagon Receptor Agonist (GRA) in Subjects with Type 1 Diabetes—A Randomized Clinical Trial
Meeting Abstracts

322-OR: SGLT2 Inhibition Has No Effect on the Counterregulatory Response to Hypoglycemia in Subjects with Type 1 Diabetes (T1D)

Free
SCHAFER C. BOEDER, DANIEL G. INES, ERIN R. GIOVANNETTI, VALA HAMIDI, PAIVI M. BURKE, ADRIENNE ARMSTRONG, LESLIE CARTER, JEREMY PETTUS
Journal: Diabetes
Diabetes 2021;70(Supplement_1):322-OR
https://doi.org/10.2337/db21-322-OR
Published: 01 June 2021
View articletitled, 322-OR: SGLT2 Inhibition Has No Effect on the Counterregulatory Response to Hypoglycemia in Subjects with Type 1 Diabetes (T1D)
Meeting Abstracts

128-LB: Effects of Glucagon Receptor Antagonism (GRA) on Ketone Body Formation during Insulinopenia in Type 1 Diabetes (T1D)

Free
SCHAFER C. BOEDER, DANIEL G. INES, LESLIE CARTER, ERIN R. GIOVANNETTI, DEBRA ARMSTRONG, PAIVI BURKE, JEREMY PETTUS
Journal: Diabetes
Diabetes 2020;69(Supplement_1):128-LB
https://doi.org/10.2337/db20-128-LB
Published: 01 June 2020
View articletitled, 128-LB: Effects of Glucagon Receptor Antagonism (GRA) on Ketone Body Formation during Insulinopenia in Type 1 Diabetes (T1D)
Journal Articles

Modulation of Circulating and Adipose Tissue Adiponectin Levels by Antidiabetic Therapy

Free
Susan A. Phillips, Theodore P. Ciaraldi, Alice P.S. Kong, Rahil Bandukwala, Vanita Aroda, Leslie Carter, Sunita Baxi, Sunder R. Mudaliar, Robert R. Henry
Journal: Diabetes
Diabetes 2003;52(3):667–674
https://doi.org/10.2337/diabetes.52.3.667
Published: 01 March 2003
View articletitled, Modulation of Circulating and Adipose Tissue Adiponectin Levels by Antidiabetic Therapy
Open the PDF for Modulation of Circulating and Adipose Tissue Adiponectin Levels by Antidiabetic Therapy in another window
Journal Articles

Inhibition of Glycogen Synthase Kinase 3 Improves Insulin Action and Glucose Metabolism in Human Skeletal Muscle

Free
Svetlana E. Nikoulina, Theodore P. Ciaraldi, Sunder Mudaliar, Leslie Carter, Kirk Johnson, Robert R. Henry
Journal: Diabetes
Diabetes 2002;51(7):2190–2198
https://doi.org/10.2337/diabetes.51.7.2190
Published: 01 July 2002
View articletitled, Inhibition of Glycogen Synthase Kinase 3 Improves Insulin Action and Glucose Metabolism in Human Skeletal Muscle
Open the PDF for Inhibition of Glycogen Synthase Kinase 3 Improves Insulin Action and Glucose Metabolism in Human Skeletal Muscle in another window